SCHEMBL25673246

SCHEMBL25673246

N#CC[C@@H]1CC(N)CCN1C(=O)/C=C/CF

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.32
KRAS P01116 1/20 0.32
TACR1 P25103 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24876293 0.85 KRAS (0.33) DPP4KRAS
SCHEMBL24876389 0.85 KRAS (0.33) DPP4KRAS
SCHEMBL25066412 0.81 KRAS (0.32) DPP4KRAS
SCHEMBL25066395 0.81 KRAS (0.32) DPP4KRAS
SCHEMBL30064865 0.75 CA1 (0.33) KRAS
SCHEMBL24543364 0.75 KRAS (0.38) DPP4KRAS
SCHEMBL25673352 0.75 TACR1 (0.32) KRASTACR1
SCHEMBL25445663 0.73
SCHEMBL24854345 0.72 KRAS (0.37) DPP4KRAS
SCHEMBL22967640 0.72 KRAS (0.37) DPP4KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091746-A1 COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR INCYTE CORPORATION (US) 2023-05-25 WO disclosed